tiprankstipranks
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Income Statement

Compare
2,251 Followers

Catalyst Pharma Income Statement

Last quarter (Q4 2024), Catalyst Pharma's total revenue was $141.82M, an increase of 28.26% from the same quarter last year. In Q4, Catalyst Pharma's net income was $55.94M. See Catalyst Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 491.73M$ 398.20M$ 214.20M$ 140.83M$ 119.07M
Gross Profit
$ 422.89M$ 313.67M$ 179.81M$ 118.95M$ 102.03M
Operating Expenses
$ 227.76M$ 259.43M$ 77.97M$ 66.56M$ 60.73M
Depreciation and Amortization
$ 0.00$ 32.88M$ 1.49M$ 484.00K$ 885.32K
EBITDA
$ 195.12M$ 119.69M$ 101.84M$ 52.38M$ 41.30M
Operating Income
$ 195.12M$ 86.81M$ 101.84M$ 52.38M$ 41.30M
Other Income/Expenses
$ 21.14M$ 7.70M$ 2.88M$ 282.00K$ 586.90K
Pretax Income
$ 216.26M$ 94.51M$ 104.72M$ 52.67M$ 41.89M
Net Income
$ 163.89M$ 71.41M$ 83.08M$ 39.48M$ 74.98M
Per Share Metrics
Basic EPS
$ 1.38$ 0.67$ 0.80$ 0.38$ 0.72
Diluted EPS
$ 1.31$ 0.63$ 0.75$ 0.37$ 0.71
Weighted Average Shares Outstanding
118.46M 106.28M 103.37M 103.38M 103.51M
Weighted Average Shares Outstanding (Diluted)
124.94M 113.75M 111.38M 107.80M 106.24M
Currency in USD

Catalyst Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis